A federal judge in Florida dismissed large chunks of the litigation alleging heartburn medication Zantac causes cancer, but plaintiffs lawyers insist the “vast majority” of their claims are moving forward.

U.S. District Judge Robin Rosenberg of the Southern District of Florida tossed claims brought under the U.S. Racketeer Influenced and Corrupt Organizations Act, as well as medical monitoring claims, which seek reimbursement for the costs of diagnostic tests that could detect cancer in the future. She also tossed the distributors from the litigation entirely and the pharmacies, such as Rite Aid and CVS, from all personal injury claims, and dismissed claims brought under the innovator liability theory, which holds brand companies liable for the labeling of generic medications.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]